D8 (RBOT)
(Delayed Data from NYSE)
$8.40 USD
+0.43 (5.40%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $8.35 -0.05 (-0.60%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$8.40 USD
+0.43 (5.40%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $8.35 -0.05 (-0.60%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth D Momentum C VGM
Zacks News
Vicarious Surgical (RBOT) Partners LSU Health New Orleans
by Zacks Equity Research
Vicarious Surgical (RBOT) teams up with LSU Health New Orleans to advance its V1.0 surgical robot. It aims to file for FDA approval by 2026.
Vicarious Surgical (RBOT) to Broaden User Network With New Deal
by Zacks Equity Research
Vicarious Surgical's (RBOT) partnership with Intermountain Health is likely to help the company gain access to Intermountain Health's extensive network.